Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. FMCX
FMCX logo

FMCX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
33.853
Open
33.853
VWAP
33.85
Vol
47.00
Mkt Cap
--
Low
33.853
Amount
1.59K
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

No data

No data

News

Globenewswire
7.5
2025-05-28Globenewswire
Ultimus Broadens Support for First Manhattan Across Private and Registered Funds
  • Ultimus Fund Solutions Expands Partnership: Ultimus Fund Solutions has expanded its relationship with First Manhattan, now providing support for both private fund structures and exchange-traded funds (ETFs), including the FM Focus Equity ETF and FM Compounders Equity ETF, following the transition of nearly $635 million in net assets from a previous service provider.

  • Enhanced Fund Administration Services: The partnership highlights Ultimus's capability to offer comprehensive fund administration services, including sophisticated accounting and reporting, which enables First Manhattan to streamline operations and focus on delivering strong financial returns to clients.

Benzinga
8.5
2025-04-14Benzinga
KKR Targets Backbone Of Global Trading With $3.1 Billion OSTTRA Acquisition
  • KKR's Acquisition of OSTTRA: KKR & Co. Inc. is acquiring OSTTRA from S&P Global and CME Group for $3.1 billion, with plans to implement an employee ownership plan for its 1,500 staff after the deal closes in late 2025.

  • Market Impact and Stock Performance: Following the announcement, KKR shares rose by 1.25%, reflecting positive investor sentiment, while the company also recently secured another acquisition deal valued at approximately €2.65 billion for Karo Healthcare.

Benzinga
8.5
2025-04-09Benzinga
KKR Outbids Competitors To Secure $2.9 Billion Karo Healthcare Takeover
  • KKR Acquires Karo Healthcare: KKR & Co. Inc. has reached an agreement to acquire Swedish consumer health firm Karo Healthcare for approximately 2.65 billion euros, outbidding rival PAI Partners, with the deal expected to close in the coming months pending regulatory approvals.

  • Impact on Healthcare Investments: This acquisition highlights KKR's commitment to healthcare investments despite a slowdown in overall merger activity, and it is anticipated to provide significant returns for EQT, which previously took Karo private and expanded its brand portfolio.

Benzinga
8.5
2025-02-24Benzinga
KKR Clinches $400 Million Deal To Take Controlling Stake In India's Cancer Hospital Chain HCG: Details
  • KKR Acquires Stake in Healthcare Global Enterprises: KKR & Co. Inc. has entered into agreements to become the largest shareholder of Healthcare Global Enterprises (HCG) by acquiring up to 54% equity for $400 million, with plans to increase ownership to 54%-77% through an open offer to public shareholders.

  • Focus on Indian Healthcare Sector: This investment aligns with KKR's strategy to enhance medical infrastructure and oncology services in India, following previous investments in various healthcare-related companies through its Asia Fund IV.

Benzinga
8.5
2025-01-27Benzinga
Emerson Electric To Buy Out AspenTech Minority Stake In $7.2 Billion Cash Deal
  • Acquisition Details: Aspen Technology, Inc. is set to be acquired by Emerson Electric Company in an all-cash tender offer of $265 per share, valuing the company at approximately $17 billion. Emerson currently owns 57% of AspenTech and plans to finance the acquisition through cash and debt.

  • Transaction Timeline: The deal is expected to close in the first half of 2025, pending customary closing conditions, and has been unanimously recommended for approval by AspenTech's Board of Directors.

Benzinga
7.5
2024-11-29Benzinga
KKR Expands Real Estate Playbook In Japan: New Venture With Weave Living Targets Over 3,000 Residential Units
  • KKR & Weave Living Partnership: KKR & Co. has formed a strategic partnership with Weave Living to manage a multi-family residential program in Japan, targeting over 3,000 units, starting with 11 newly acquired properties in Tokyo.

  • Investment and Market Strategy: The initiative aims to leverage Weave Living's management capabilities to innovate Japan's rental housing market, building on their previous collaboration in South Korea, while KKR continues to expand its real estate portfolio in the region.

Wall Street analysts forecast FMCX stock price to rise
0 Analyst Rating
Wall Street analysts forecast FMCX stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (FMCX) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

a non volital etf
Intellectia · 4574 candidates
Monthly Average Dollar Volume: >= 0
Ticker
Name
Market Cap$
top bottom
CALY logo
CALY
NaN
DULL logo
DULL
MicroSectors Gold -3X Inverse Leveraged ETNs due January 29, 2043
NaN
DZZ logo
DZZ
DB Gold Double Short ETN due February 15, 2038
NaN
PMAU logo
PMAU
PGIM S&P 500 Max Buffer ETF - August
NaN
PMJN logo
PMJN
PGIM S&P 500 Max Buffer ETF - June
NaN
RVRB logo
RVRB
Reverb ETF
NaN

Whales Holding FMCX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (FMCX) stock price today?

The current price of FMCX is 33.8532 USD — it has increased 1.17

What is (FMCX)'s business?

What is the price predicton of FMCX Stock?

Wall Street analysts forecast FMCX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FMCX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (FMCX)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (FMCX)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (FMCX). have?

(FMCX) has 0 emplpoyees as of March 05 2026.

What is (FMCX) market cap?

Today FMCX has the market capitalization of 0.00 USD.